Foundation Medicine: Mia Levy
Roche subsidiary Foundation Medicine announced it has appointed medical oncologist Mia Levy as CMO. Levy specializes in breast cancer treatment and biomedical informatics and previously served as director of the Cancer Center at Rush University Medical Center. She led the development of My Cancer Genome, an international resource for clinicians and patients to get information about cancer-driving mutations, clinical trials, and therapies.
Levy has also served as an associate professor of cancer research, biomedical informatics, and medicine at Vanderbilt University, as well as the director of clinical cancer informatics for the Vanderbilt-Ingram Cancer Center.
She is a member of the National Cancer Policy Forum for the National Academies and a member of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee.